MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$36,364M
Net Income
$4,801M
Net Profit Margin
13.20%
EPS
$3.73
Unit: Million (M) dollars
Revenue Breakdown
Total Other Countries Excluding ...
US
IE
Revenue Breakdown
Cardiac Rhythm And Heart Failure...
Surgical Endoscopy
Cranial And Spinal Technologies ...
Others
Revenue Breakdown
Cardiovascular
Neuroscience Group
Medical Surgical
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Income Statement
2026-04-24
2025-04-25
2024-04-26
2023-04-28
Net sales
36,364
33,537
32,364
31,227
Cost of products sold, excluding amortization of intangible assets
12,721
11,632
11,216
10,719
Research and development expense
2,873
2,732
2,735
2,696
Selling, general, and administrative expense
11,784
10,849
10,736
10,415
Amortization of intangible assets
1,772
1,807
1,693
1,698
Restructuring charges, net
249
267
226
375
Certain litigation charges, net
113
317
149
-30
Other operating expense (income), net
-386
23
-464
131
Operating profit
6,467
5,955
5,144
5,485
Other non-operating expense (income), net
384
402
412
515
Interest expense, net
715
729
719
636
Income before income taxes
6,136
5,628
4,837
5,364
Income tax provision
1,299
936
1,133
1,580
Net income
4,837
4,691
3,705
3,784
Net income attributable to noncontrolling interests
37
29
28
26
Net income attributable to medtronic
4,801
4,662
3,676
3,758
Basic EPS
3.75
3.63
2.77
2.83
Diluted EPS
3.73
3.61
2.76
2.82
Basic Average Shares
1,281,800,000
1,285,600,000
1,327,700,000
1,329,800,000
Diluted Average Shares
1,288,100,000
1,289,900,000
1,330,200,000
1,332,800,000
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
3
Total Other Countries
Excluding United...
$18,118M
(11.50%↑ Y/Y)
US
$18,103M
(5.43%↑ Y/Y)
Total Other Countries
Excluding Ireland
$36,221M
(8.38%↑ Y/Y)
IE
$143M
(23.28%↑ Y/Y)
Net sales
$36,364M
(8.43%↑ Y/Y)
Operating profit
$6,467M
(8.60%↑ Y/Y)
Other non-operating
expense (income), net
$384M
(-4.48%↓ Y/Y)
Cost of products
sold, excluding...
$12,721M
(9.36%↑ Y/Y)
Selling, general, and
administrative expense
$11,784M
(8.62%↑ Y/Y)
Research and development
expense
$2,873M
(5.16%↑ Y/Y)
Amortization of intangible
assets
$1,772M
(-1.94%↓ Y/Y)
Other operating
expense (income), net
-$386M
(-1778.26%↓ Y/Y)
Restructuring charges, net
$249M
(-6.74%↓ Y/Y)
Certain litigation
charges, net
$113M
(-64.35%↓ Y/Y)
Income before income
taxes
$6,136M
(9.03%↑ Y/Y)
Interest expense, net
$715M
(-1.92%↓ Y/Y)
Net income
$4,837M
(3.11%↑ Y/Y)
Income tax provision
$1,299M
(38.78%↑ Y/Y)
Net income
attributable to medtronic
$4,801M
(2.98%↑ Y/Y)
Net income
attributable to...
$37M
(27.59%↑ Y/Y)
Buy us a coffee
Medtronic_logo-svg (2)-svg
Medtronic plc (MDT)
Medtronic_logo-svg (2)-svg
Medtronic plc (MDT)